Características clínicas y supervivencia en pacientes pediátricos oncohematológicos con COVID-19 en un hospital de referencia del Seguro Social de Salud del Perú, durante el 2020-2021
DOI:
https://doi.org/10.35434/rcmhnaaa.2023.161.1702Palabras clave:
COVID-19, Neoplasias, Leucemia, Niño, Pediatría, PerúResumen
Introducción: En Latinoamérica, existen pocos estudios y resultados heterogéneos sobre pacientes pediátricos oncohematológicos con COVID-19. Objetivo: Describir las características clínicas y la supervivencia de pacientes pediátricos oncohematológicos con COVID-19 en un hospital de Lima-Perú, 2020-2021. Métodos: Estudio longitudinal retrospectivo de pacientes menores de 14 años hospitalizados. Los datos se recolectaron de las historias clínicas. Resultados: Incluimos 30 pacientes, mayoría hombres y escolares, predominando la fiebre, síntomas respiratorios y gastrointestinales, la neoplasia hematológica, y la enfermedad oncológica avanzada. La mayoría desarrolló enfermedad leve-moderada, pero también presentaron evolución severa con requerimiento de soporte crítico, con mortalidad alta en hospitalización (13,3%) y baja supervivencia durante el seguimiento (a los 526 días, 59,26%, IC95% 36,53 a 76,20%). La supervivencia aumentó con reinicio de la quimioterapia , y disminuyó en pacientes de condición paliativa, con soporte respiratorio y shock. Conclusiones: La mayoría desarrolló enfermedad leve-moderada. Sin embargo, el SARS-CoV-2 también puede causar afectación severa, muerte y baja supervivencia en pacientes oncohematológicos.
Descargas
Métricas
Citas
Tsankov BK, Allaire JM, Irvine MA, Lopez AA, Sauvé LJ, Vallance BA, et al. Severe COVID-19 Infection and Pediatric Comorbidities: A Systematic Review and Meta-Analysis. Int J Infect Dis. 2021;103:246-56. doi: 10.1016/j.ijid.2020.11.163
Węcławek-Tompol J, Zakrzewska Z, Gryniewicz-Kwiatkowska O, Pierlejewski F, Bień E, Zaucha-Prażmo A, et al. COVID-19 in pediatric cancer patients is associated with treatment interruptions but not with short-term mortality: a Polish national study. J Hematol Oncol. 2021;14(1):163. doi: 10.1186/s13045-021-01181-4
Global Health Research Group on Children’s Non-Communicable Diseases Collaborative. Impact of the COVID-19 pandemic on patients with paediatric cancer in low-income, middle-income and high-income countries: a multicentre, international, observational cohort study. BMJ Open. 2022;12(4):e054690. doi: 10.1136/bmjopen-2021-054690
Johnston EE, Martinez I, Davis ES, Caudill C, Richman J, Brackett J, et al. SARS-CoV-2 in Childhood Cancer in 2020: A Disease of Disparities. J Clin Oncol. 2021;39(34):3778-88. doi: 10.1200/JCO.21.00702
Mukkada S, Bhakta N, Chantada GL, Chen Y, Vedaraju Y, Faughnan L, et al. Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study. Lancet Oncol. 2021;22(10):1416-26. doi: 10.1016/S1470-2045(21)00454-X
Dorantes-Acosta E, Ávila-Montiel D, Klünder-Klünder M, Juárez-Villegas L, Márquez-González H. Survival and Complications in Pediatric Patients With Cancer and COVID-19: A Meta-Analysis. Front Oncol. 2020;10:608282. doi: 10.3389/fonc.2020.608282
Meena JP, Kumar Gupta A, Tanwar P, Ram Jat K, Mohan Pandey R, Seth R. Clinical presentations and outcomes of children with cancer and COVID-19: A systematic review. Pediatr Blood Cancer. 2021;68(6):e29005. doi: 10.1002/pbc.29005
Majeed A, Wright T, Guo B, Arora RS, Lam CG, Martiniuk AL. The Global Impact of COVID-19 on Childhood Cancer Outcomes and Care Delivery - A Systematic Review. Front Oncol. 2022;12:869752. doi: 10.3389/fonc.2022.869752
Schlage S, Lehrnbecher T, Berner R, Simon A, Toepfner N. SARS-CoV-2 in pediatric cancer: a systematic review. Eur J Pediatr. 2022;181(4):1413-27. doi: 10.1007/s00431-021-04338-y
Palomo-Collí MÁ, Fuentes-Lugo AD, Cobo-Ovando SR, Juárez-Villegas L. COVID-19 in Children and Adolescents With Cancer From a Single Center in Mexico City. J Pediatr Hematol Oncol. 2021;43(7):e1047-8. doi: 10.1097/MPH.0000000000002040
Lima ALM de A, Borborema M do CD, Matos APR, Oliveira KMM de, Mello MJG, Lins MM. COVID-19 cohort on children with cancer: delay in treatment and increased frequency of deaths. Rev Bras Saúde Materno Infant. 2021;21:299-304. doi: 10.1590/1806-9304202100S100017
Sánchez-Jara B, Torres-Jiménez AR, Del Campo-Martinez M de los A, Ortíz-Torres MG, García-Soto A, Loza-Santiaguillo P del R, et al. Clinical characteristics and evolution of pediatric patients with acute leukemia and SARS-COV2 virus infection in a third level hospital in Mexico. Pediatr Hematol Oncol J. 2021;6(1):42-8. doi: 10.1016/j.phoj.2020.11.001
Fonseca EV, Pardo CA, Linares A, López JF, Camacho G, Aponte NH, et al. Clinical Characteristics and Outcomes of a Cohort of Pediatric Oncohematologic Patients With COVID-19 Infection in the City of Bogotá, Colombia. Pediatr Infect Dis J. 2021;40(6):499-502. doi: 10.1097/INF.0000000000003135
Corso MCM, Soares VJ, Amorim AMP, Cipolotti R, Magalhães IMQ, Lins MM, et al. SARS-CoV-2 in children with cancer in Brazil: Results of a multicenter national registry. Pediatr Blood Cancer. 2021;68(12):e29223. doi: 10.1002/pbc.29223
Dominguez-Rojas JÁ, Vásquez-Hoyos P, Pérez-Morales R, Monsalve-Quintero AM, Mora-Robles L, Diaz-Diaz A, et al. Association of Cancer Diagnosis and Therapeutic Stage With Mortality in Pediatric Patients With COVID-19, Prospective Multicenter Cohort Study From Latin America. Front Pediatr. 2022;10:885633. doi: 10.3389/fped.2022.885633
Nicastro E, Verdoni L, Bettini LR, Zuin G, Balduzzi A, Montini G, et al. COVID-19 in Immunosuppressed Children. Front Pediatr. 2021;9:629240. doi: 10.3389/fped.2021.629240
The World Bank. The World by Income and Region [Internet]. [citado 10 de noviembre de 2022]. Disponible en: https://datatopics.worldbank.org/world-development-indicators/the-world-by-income-and-region.html
Herrera-Añazco P, Uyen-Cateriano A, Mezones-Holguin E, Taype-Rondan A, Mayta-Tristan P, Malaga G, et al. Some lessons that Peru did not learn before the second wave of COVID-19. Int J Health Plann Manage. 2021;36(3):995-8. doi: 10.1002/hpm.3135
COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet. 2022;399(10334):1513-36. doi: 10.1016/S0140-6736(21)02796-3
Munayco CV, Tariq A, Rothenberg R, Soto-Cabezas GG, Reyes MF, Valle A, et al. Early transmission dynamics of COVID-19 in a southern hemisphere setting: Lima-Peru: February 29th–March 30th, 2020. Infect Dis Model. 2020;5:338-45. doi: 10.1016/j.idm.2020.05.001
Rouger-Gaudichon J, Bertrand Y, Boissel N, Brethon B, Ducassou S, Gandemer V, et al. COVID19 and acute lymphoblastic leukemias of children and adolescents: Updated recommendations (Version 2) of the Leukemia Committee of the French Society for the fight against Cancers and leukemias in children and adolescents (SFCE). Bull Cancer (Paris). 2021;108(5):490-500. doi: 10.1016/j.bulcan.2021.02.004
Bogaert B, Buisson V, Kozlakidis Z, Saintigny P. Organisation of cancer care in troubling times: A scoping review of expert guidelines and their implementation during the COVID-19 pandemic. Crit Rev Oncol Hematol. 2022;173:103656. doi: 10.1016/j.critrevonc.2022.103656
Cesaro S, Ljungman P, Mikulska M, Hirsch HH, von Lilienfeld-Toal M, Cordonnier C, et al. Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9). Leukemia. 2022;36(6):1467-80. doi: 10.1038/s41375-022-01578-1
Descargas
Publicado
Cómo citar
Número
Sección
Categorías
Licencia
Derechos de autor 2023 Giancarlo Alvarado-Gamarra, Jesús Dominguez-Rojas, Noé Atamari-Anahui, Vanessa Zarate-Campos, Sarah Fernández Suárez, Eva Vásquez-Gamarra, Ninoska Rojas-Soto, Raquel Garcés-Ghilardi, Matilde Estupiñan-Vigil
Esta obra está bajo una licencia internacional Creative Commons Atribución 4.0.
